Deltex Medical Group plc
Deltex Medical Group plc (DTXMF) Revenue
Annual & quarterly revenue history · segment & region breakdown
DTXMF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsDeltex Medical Group plc trailing twelve-month (TTM) revenue is $0.00B, an increase of 15.77% year-over-year from $0.00B in FY2024.
Revenue trend
2024 – 2005 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2024-12-31 | $0.00B | +$0.00B | +15.77% |
| 2023-12-31 | $0.00B | -$0.00B | -28.44% |
| 2022-12-31 | $0.00B | +$0.00B | +9.87% |
| 2021-12-31 | $0.00B | -$0.00B | -5.80% |
| 2020-12-31 | $0.00B | -$0.00B | -43.66% |
| 2019-12-31 | $0.00B | -$0.00B | -14.11% |
| 2018-12-31 | $0.00B | -$0.00B | -15.59% |
| 2017-12-31 | $0.01B | -$0.00B | -7.28% |
| 2016-12-31 | $0.01B | -$0.00B | -1.16% |
| 2015-12-31 | $0.01B | -$0.00B | -1.57% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Deltex Medical Group plc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Deltex Medical Group plc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in GBP.
Data sourced from Deltex Medical Group plc's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
DTXMF revenue · 4 questionsDTXMF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 15.77% year-over-year from $0.00B in FY2024.
▸ Source: FMP · Deltex Medical Group plc SEC filings · GAAP · Deltex Medical Group plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026